The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible.
Researchers at the University of California, San Diego School of Medicine, led by Larry R. Squire, PhD, professor of psychiatry, psychology and neurosciences at UC San Diego and a scientist at the VA San Diego Healthcare System, report that working memory of relational information – where an object is located, for example – remains intact even if key brain structures like the hippocampus are damaged.
The National Institutes of Health has chosen Neil Chi, MD, PhD, assistant professor of medicine in the division of cardiology at the University of California, San Diego, as one of its 2010 NIH Director’s New Innovator Award recipients.
Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.
A new study, derived from novel sleep research conducted by University of California, San Diego researchers 14 years earlier, suggests that the secret to a long life may come with just enough sleep. Less than five hours a night is probably not enough; eight hours is probably too much.
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions.
A study led by researchers at the University of California, San Diego shows that California’s 40 year-long tobacco control program has resulted in lung cancer rates that are nearly 25 percent lower than other states.
Surgeons at the University of California, San Diego, School of Medicine and University of Washington Medical Center have determined that transorbital neuroendoscopic surgery (TONES) is a safe and effective option for treating a variety of advanced brain diseases and traumatic injuries.
The emerging idea that obesity may have an infectious origin gets new support in a cross-sectional study by University of California, San Diego School of Medicine researchers who found that children exposed to a particular strain of adenovirus were significantly more likely to be obese.
Investigators, led by researchers at the University of California, San Diego, have mapped a huge network of protein interactions involving Mitogen Activated Protein Kinase (MAPK) pathways. Their study will be published in the advanced online edition of Nature Methods on September 19.
Elevated levels of a growth protein in the brains of Alzheimer’s disease (AD) patients is linked to impaired neurogenesis, the process by which new neurons are generated, say researchers at the University of California, San Diego in today’s edition of The Journal of Neuroscience.
Moores UCSD Cancer Center at the University of California, San Diego has been designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR).
An international team of scientists, led by researchers at the University of California, San Diego, has identified misfolding and other molecular anomalies in a key brain protein associated with autism spectrum disorders.
Researchers at the University of California, San Diego School of Medicine have identified “secondary over-triage” as a potential area of cost savings for our nation’s health care.
Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology at the University of California, San Diego School of Medicine has been awarded the 2010 Harvey Prize in human health by the Technion, Israel’s premier institute of technology.
A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer’s disease (AD).
Scientists from the University of California, San Diego School of Medicine have identified dendritic antigen-presenting cells in zebrafish, opening the possibility that the tiny fish could become a new model for studying the complexities of the human immune system.
An international team, led by University of California, San Diego School of Medicine researchers, has been awarded a $6.5 million grant from the National Institutes of Health (NIH) to study the pharmacogenomics of a key mood-stabilizing drug used to treat bipolar disorder.
Using eye-tracking methods, researchers at UCSD School of Medicine have shown that toddlers with autism spend significantly more time visually examining dynamic geometric patterns than they do looking at social images – a viewing pattern not found in either typical or developmentally delayed toddlers.
Researchers at the University of California, San Diego have revealed new details about how cannibalistic bacteria identify peers suitable for consumption. The work, which employed imaging mass spectrometry, is a first step toward a broader effort to map all signaling molecules between organisms
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.
Robert G. Gish, MD, world-renowned hepatologist, has been recruited to the University of California, San Diego School of Medicine to co-direct the Center for Hepatobiliary Disease and Abdominal Transplantation (CHAT) ─ a multidisciplinary program designed to offer adult and pediatric patients in the western United States a single destination for the diagnosis and treatment of liver disease from common to complex.
In a paper published in the September issue of the Journal of Lipid Research, a team of scientists, led by researchers at the University of California, San Diego School of Medicine, has mapped for the first time the actual locations of specific lipids within a single cell.
UC San Diego Professor of Family and Preventive Medicine, Frank Garland, PhD, died Tuesday, August 17 in La Jolla, California, after a year-long battle with illness. Garland was also Technical Director of the Naval Health Research Center.
Malignant gliomas are the most common subtype of primary brain tumor – and one of the deadliest.
Surgeons at the University of California, San Diego School of Medicine have achieved what is believed to be the nation’s first stomach reduction via the mouth. The novel weight loss procedure, known as a sleeve gastrectomy, reduces the stomach to 20 percent of its original size.
Researchers at the University of California, San Diego School of Medicine have identified a new way to regulate the uncontrolled growth of blood vessels, a major problem in a broad range of diseases and conditions.
The six-site Consortium on the Genetics of Schizophrenia (COGS), led by the director of the Schizophrenia Program at the University of California, San Diego School of Medicine, has received a $10 million renewal grant from the National Institute of Mental Health (NIMH), one of the National Institutes of Health.
Surgeons at the University of California, San Diego School of Medicine continue to advance minimally-invasive surgery for cancer patients by reducing the number of abdominal incisions from approximately six to a single small incision.
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue.
Researchers at the University of California, San Diego School of Medicine received nearly $780,000 from the Susan G. Komen for the Cure® for two studies regarding estrogen levels and the behavior of breast cancer tumors.
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, has discovered the gene mutation responsible for a condition in which eye and brain development is severely disrupted in affected infants. They also suggest a potential remedy that would involve a simple, daily dietary supplement.
The University of California, San Diego Health Sciences and its expanding Clinical and Translational Research Institute (CTRI) have received a five-year, $37.2 million Clinical and Translational Science Award from the National Center for Research Resources (NCRR), part of the National Institutes of Health.
A new study of breast cancer patients at the Moores UCSD Cancer Center and the Arizona Oncology Services shows that after almost two years, the radiation given with the Strut-Adjusted Volume Implant (SAVI™) controls the rate of cancer and may reduce the complications seen with alternate types of brachytherapy.
Tropical disease specialist Joseph Vinetz, MD, of the University of California, San Diego School of Medicine will lead an ambitious multi-national effort to help control and eventually conquer malaria, establishing a new Peruvian/Brazilian International Center of Excellence in Malaria Research Center (ICEMR) with a seven-year, $9.2 million grant from the National Institutes of Health.
As part of the only U.S. prospective multicenter clinical trial to compare natural orifice translumenal endoscopic surgery (NOTES) to laparoscopy, surgeons at the University of California, San Diego School of Medicine have performed the trial’s first oral gallbladder removal.
A new study by researchers at the University of California, San Diego School of Medicine finds that a comparable region in the brains of chickens concerned with analyzing auditory inputs is constructed similarly to that of mammals.
Jonathan Sebat, PhD, a pioneering young geneticist whose focus is psychiatric disorders such as autism and schizophrenia, has been named the first chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases at the University of California, San Diego.
A team of researchers from the University of California San Diego and Mexico has found that even a modest behavioral intervention program averaging just 35 minutes can measurably reduce the incidence of HIV and sexually transmitted infections (STIs) among female sex workers in the U.S.-Mexico border region – and that the program succeeds at comparatively little expense.
We usually scold our children and teenagers for watching too much TV. It turns out that their grandmas and grandpas spend even more of their time watching TV, and it is not good for them either, according to researchers at the Stein Institute for Research on Aging and Rady School of Management at the University of California, San Diego School of Medicine.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson’s disease.
The University of California, San Diego School of Medicine has received a $5.3 million grant from the National Cancer Institute to conduct and lead a first-of-its-kind, four-year clinical trial to show the effects of weight loss and increased physical activity on quality of life and on co-existing medical conditions in overweight breast cancer survivors.
A pair of University of California San Diego researchers – Martin Marsala, a specialist in spinal cord trauma and disorders, and Yang Xu, an immunologist – have been awarded more than $2.5 million in new grants from the California Institute for Regenerative Medicine (CIRM).
Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine (CIRM) will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
In diverse neurodegenerative diseases ranging from Parkinson’s to Alzheimer’s, researchers have long noted accumulations of a little-understood neuronal protein called α-synuclein. Pathological and genetic evidence strongly suggested that excessive α-synuclein played a role in the evolution of these diseases, but it was unclear how too much α-synuclein culminated in synaptic damage and neurodegeneration.
The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego in La Jolla, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain tumors that start in the brain or spinal cord tissue. Annually, about 17,000 Americans are diagnosed with gliomas, which are difficult to treat and often fatal.
Community-based HIV testing programs generally use only HIV antibody testing, but nucleic acid testing (NAT) can detect the presence of HIV earlier. Researchers at the UCSD School of Medicine studied more than 3,000 patients who sought HIV testing in community-based clinics in or near San Diego to examine the yield of testing with a rapid test plus NAT and to see whether patients would be willing to access their results by phone or computer.
Neuroscientists at the University of California, San Diego School of Medicine have found that removing three key inhibitory molecules from myelin – the insulating material that surrounds nerve cell fibers – does not significantly boost the ability of injured spinal axons to regenerate and restore themselves to full function.
Full-Service Partnerships (FSPs) are designed to do ‘whatever it takes’ to improve residential stability and mental health outcomes for homeless persons with serious mental illness. They are the cornerstone of California’s Mental Health Services Act (MHSA) – one of the largest mental health policy experiments in recent history.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right